1 / 10

Aarkstore - Vasculitis - Pipeline Review, H2 2014

Vasculitis - Pipeline Review, H2 2014 report reviews key players involved in the therapeutic development for Vasculitis and special features on late-stage and discontinued projects. Browse full report @ http://goo.gl/x5IUxC

kaveriRai9023
Download Presentation

Aarkstore - Vasculitis - Pipeline Review, H2 2014

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Healthcare Market Research Report Vasculitis - Pipeline Review, H2 2014 For More Information Visit : www.aarkstore.com

  2. Summary Vasculitis - Pipeline Review, H2 2014, provides an overview of the Vasculitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Vasculitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vasculitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. For More Information Visit : www.aarkstore.com

  3. Scope - The report provides a snapshot of the global therapeutic landscape of Vasculitis- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Vasculitis and enlists all their major and minor projects- The report summarizes all the dormant and discontinued pipeline projects - A review of the Vasculitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages Browse full report or Sample Request @ • http://www.aarkstore.com/healthcare/89757/vasculitis-pipeline-review-h2-2014 For More Information Visit : www.aarkstore.com

  4. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop strategic initiatives by understanding the focus areas of leading companies- Identify and understand important and diverse types of therapeutics under development for Vasculitis- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline- Devise corrective measures for pipeline projects by understanding Vasculitis pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline For More Information Visit : www.aarkstore.com

  5. Table of Content Introduction 7Global Markets Direct Report Coverage 7Vasculitis Overview 8Therapeutics Development 9Pipeline Products for Vasculitis - Overview 9Pipeline Products for Vasculitis - Comparative Analysis 10Vasculitis - Therapeutics under Development by Companies 11Vasculitis - Pipeline Products Glance 13Late Stage Products 13Clinical Stage Products 14Early Stage Products 15Vasculitis - Products under Development by Companies 16Vasculitis - Companies Involved in Therapeutics Development 17AnGes MG, Inc. 17Anthera Pharmaceuticals Inc. 18Aprogen, Inc. 19ChemoCentryx, Inc. 20 For More Information Visit : www.aarkstore.com

  6. List of Tables Number of Products under Development for Vasculitis, H2 2014 9Number of Products under Development for Vasculitis - Comparative Analysis, H2 2014 10Number of Products under Development by Companies, H2 2014 11Comparative Analysis by Late Stage Development, H2 2014 13Comparative Analysis by Clinical Stage Development, H2 2014 14Comparative Analysis by Early Stage Development, H2 2014 15Products under Development by Companies, H2 2014 16Vasculitis - Pipeline by AnGes MG, Inc., H2 2014 17Vasculitis - Pipeline by Anthera Pharmaceuticals Inc., H2 2014 18Vasculitis - Pipeline by Aprogen, Inc., H2 2014 19Vasculitis - Pipeline by ChemoCentryx, Inc., H2 2014 20Vasculitis - Pipeline by ClearsideBioMedical, Inc., H2 2014 21Vasculitis - Pipeline by Epirus Biopharmaceuticals, Inc., H2 2014 22Vasculitis - Pipeline by F. Hoffmann-La Roche Ltd., H2 2014 23Vasculitis - Pipeline by GlaxoSmithKline plc, H2 2014 24Vasculitis - Pipeline by Hemostemix Ltd, H2 2014 25 For More Information Visit : www.aarkstore.com

  7. List of Figures Number of Products under Development for Vasculitis, H2 2014 9Number of Products under Development for Vasculitis - Comparative Analysis, H2 2014 10Number of Products under Development by Companies, H2 2014 11Comparative Analysis by Clinical Stage Development, H2 2014 14Comparative Analysis by Early Stage Products, H2 2014 15Assessment by Monotherapy Products, H2 2014 32Number of Products by Top 10 Targets, H2 2014 33Number of Products by Stage and Top 10 Targets, H2 2014 33Number of Products by Top 10 Mechanism of Actions, H2 2014 35Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 35Number of Products by Top 10 Routes of Administration, H2 2014 37Number of Products by Stage and Top 10 Routes of Administration, H2 2014 37Number of Products by Top 10 Molecule Types, H2 2014 39Number of Products by Stage and Top 10 Molecule Types, H2 2014 39 For More Information Visit : www.aarkstore.com

  8. Related Reports United States Off–Label Drugs Market & Forecast Canada Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast Intrauterine Contraceptive Devices Market (IUD/IUCD),by Type [Hormonal IUCD, Copper IUCD] – Global Forecast to 2019 Asian Healthcare Workflow Systems Market by Type (Fraud Detection, Pharmacy Audit & Analysis, Claim Management System, Customer Relationship Management), by End-User - Forecast to 2019 Healthcare IT (HIT) Market in the APAC Region 2015-2019 Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report Global Healthcare BPO Market 2015-2019 For More Information Visit : www.aarkstore.com

  9. Follow Us https://www.facebook.com/aarkstoredotcom https://twitter.com/aarkstore https://plus.google.com/+Aarkstoredotcom/posts https://www.linkedin.com/company/aarkstore-enterprise For More Information Visit : www.aarkstore.com

  10. Contact Us Office Address Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Mail us at contact@aarkstore.com 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 For More Information Visit : www.aarkstore.com

More Related